Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2007Clinical Cancer Research

Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYvonne G. LinFlorida State UniversityAKAjaikumar B. KunnumakkaraIndian Institute of Technology GuwahatiSNS. Asha NairLuton and Dunstable University Hospital NHS Foundation Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lin et al. (2007) studied this question.

synapsesocial.com/papers/6a9255928356c7bfaac80c00https://doi.org/10.1158/1078-0432.ccr-06-3072
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer2001 · 1,587 citations
  2. 2Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer2007 · 147 citations
  3. 3Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer2005 · 120 citations
  4. 4Evodiamine Abolishes Constitutive and Inducible NF-κB Activation by Inhibiting IκBα Kinase Activation, Thereby Suppressing NF-κB-regulated Antiapoptotic and Metastatic Gene Expression, Up-regulating Apoptosis, and Inhibiting Invasion2005 · 172 citations
  5. 5Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of Apoptosis2004 · 186 citations